Author

Zofia Novotny Page 3

A cancer immunotherapy researcher who began working in laboratory science in 2000, Zofia Novotny runs CAR-T and tumor-model experiments at an academic lab in Boston, Massachusetts. She turned to bench research after briefly considering genetic counseling, holding degrees in molecular biology and biotechnology. A distance runner in her off hours, Novotny covers cancer therapy developments for Biology Insights.

CCNE1 Amplification: What It Is and Its Role in Cancer Cancer
FFPE Tumor: Its Role in Cancer Diagnosis and Research Cancer
What Is TCR Therapy? How It Works and Its Applications Cancer
The VISTA Immune Checkpoint: A Target in Cancer Therapy Cancer
What Are the Approved T-Cell Engagers for Cancer?Cancer
TIGIT Clinical Trials for Cancer: A Status Update Cancer
What Is Anti-TIGIT Therapy and How Does It Work?Cancer
What Is an IL-15 Superagonist and How Does It Work?Drugs
Why Was Saracatinib Discontinued for Cancer Treatment?Cancer
What Is CAR T-Cell Persistence and Why Is It Important?Cancer
What Is CAR T Expansion and Why Is It Important?Cancer
Two Hit Hypothesis: How Tumor Suppressor Genes Are Silenced Cancer
p53 Target Genes and Their Role in Cancer Biology Cancer
Cancer Driver Genes: Their Critical Role in Tumor Development Genetics
SKBR3: Notable Breakthroughs in Breast Cancer Cell Science Cancer
Ki67 IHC: A Closer Look at Its Role in Tumor Profiling Tests
Cancer Mouse Models: Breakthroughs in Oncoimmunology Cancer
Prostate Cancer Cell Lines: Current Varieties & Key Traits Cancer